NCT Number: NCT00123396
VHA Clinicians and Bioterror Events: Interactive Web-based Learning
Our 4-year project uses public domain software and content developed by a University of Alabama at Birmingham (UAB) team and updates, refines, and tailors it to the unique clinician populations and electronic educational applications of VAMCs We are testing an innovative, web-based intervention adapted specifically for the VA to increase syndromic recognition, treatment, and post-exposure prophylaxis of biological warfare agents at multiple VA sites via a randomized controlled trial (RCT). Ultimately, we will disseminate the intervention throughout the entire VA system.
Looking for future studies?
Notify MeKey information
Conditions
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
Birmingham VA Medical Center, Birmingham, AL, Birmingham, Alabama, United States
About this study
Background:
Because of VA's long history in disaster preparedness, and the crucial role VA providers will play, the VA medical system has the potential to make an enormous difference in outcomes following a bioterror attack or infectious outbreak. A 2002 AHRQ report reviewed 60 studies and found that very few bioterrorism preparedness training programs were rigorously evaluated. Our project was the first effort to formally test and implement a bioterrorism preparedness intervention in the VA healthcare system. Because Internet-delivered interventions have the potential for wide dissemination, we used the Internet to implement the Intervention.
Objectives:
- To develop, tailor, and continuously update and validate evidence- and scenario-based electronic teaching and testing modules to increase VA clinicians' knowledge of Category A biological warfare agents. We refer to these instruments as Bioterrorism Case Analysis and Skills Enhancement Sessions (BioCASES) and Bioterrorism Skills Test Sessions (BioTESTS).
- To test the effectiveness of the BioCASES teaching modules by way of a randomized controlled trial of VAMCs using the BioTESTS to evaluate their effectiveness for increasing and sustaining VA clinician knowledge, skills, and ability to respond to bioterrorism events.
- To continue to develop and adapt BioCASES and BioTESTS for use in VA CME programs. Ultimately, we will disseminate the intervention throughout the entire VA system.
Methods:
Our project team developed or refined and updated a total of 12 educational modules focusing on CDC's Category A agents and other emerging infectious diseases. We developed post-test instruments and case-based scenarios germane to the VA patient population for anthrax and smallpox. Materials were designed specifically for the unique clinician populations and electronic educational applications available in VAMCs. Website functionality and content were refined using the nominal group technique and "thinking aloud" protocols. We tested our innovative, web-based educational intervention at fifteen VA facilities via a randomized controlled trial (RCT).
Status:
The intervention has been completed. Fifteen sites were randomized and completed the study processes.
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Clinicians at participating facilities who work in a primary care setting (ED, MOD, general medicine, primary care, or CBOC).
Exclusion criteria
Facilities will be excluded from the project that 1)choose not to participate, or 2)do not have the minimum number of clinicians needed.
Treatment and study plan
Primary outcomes
-
The outcome measure will be performance on post-test administered immediately and at 3 months and 6 months post intervention. Performance on the post-test administered at three months will be considered the main outcome of the study.
Time frame: 3 months
Secondary outcomes
-
The 6-month tests will be given to demonstrate the sustainability of the intervention (prevention of decay effect).
Sponsors and collaborators
Lead sponsor
US Department of Veterans Affairs
Fed
Collaborators
- University of Alabama at Birmingham
Registry information
Important dates
- Study start
- 2004
- Primary completion
- 2006
- Study completion
- 2007
- First posted
- Jul 22, 2005
- Registry last updated
- Apr 7, 2015
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
MVA Post-Event: Administration Timing and Boost Study
NCT00437021
DNA Virus Infections, Infections
Iowa City, Iowa, United States
View Trial DetailsA Study to Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared With Placebo in Healthy Participants From ≥18 Years of Age to <50 Years of Age
NCT05995275
Animal Diseases, DNA Virus Infections
Bradford, United Kingdom
View Trial DetailsHigh Dose IMVAMUNE® in Vaccinia-Naive Individuals
NCT00879762
DNA Virus Infections, Infections
Iowa City, Iowa, United States
View Trial DetailsStudy Evaluating the Bioequivalence of Brincidofovir Form H and Form II Tablets in Healthy Adults
NCT05935917
DNA Virus Infections, Infections
Overland Park, Kansas, United States
View Trial Details